PharmTech Drug Digest 11.20
News|Articles|October 23, 2014

Drug Repackaging Company Recalls Tablets Due to Packaging Mix-Up

Contract Packaging Resources issued a voluntary recall of naproxen sodium tablets because some cartons contain bottles of ibuprofen.

Contract Packaging Resources, a drug repackaging company, is voluntarily recalling 11,640 boxes of Assured brand naproxen sodium tablets because some cartons contain bottles of ibuprofen, a different pain reliever. The ibuprofen bottles were placed in the naproxen sodium boxes due to a packaging error. The affected products are: boxes of Assured brand naproxen sodium tablets 220 mg, 15 count (Lot #FH4102A) [SKU #122368/UPC #639277223685] containing bottles of ibuprofen softgels in 200-mg strength.

The recalled Assured-brand drug products were distributed nationwide to Dollar Tree and sold through Dollar Tree retail stores and website. Contract Packaging Resources is notifying its distributors and customers directly and arranging for replacement of all recalled products.

Source: FDA


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.